Indefinite Delivery Contract SPE2DB22D9353

The Defense Logistics Agency awarded an indefinite delivery contract to DMS Pharmaceutical Group Inc. to provide pharmaceutical products and medical supplies in support of DOD programs. The IDIQ has a potential value of $499,999,999 and period of performance through December 2025.

Under the contract, DMS Pharmaceutical Group will deliver a variety of prescription drugs, medical devices, and other supplies from its facility in Park Ridge, Illinois on a series of fixed price delivery orders. Products include medications for conditions like cystic fibrosis, cancer, and eye diseases. Medical supplies encompass items like surgical kits, vaccines, and anesthetics. Delivery orders have values ranging from under $400 to over $4 million, with periods of performance from one to 90 days depending on the requirements.

The DLA is the logistics and procurement agency supporting all branches of the U.S. armed forces. This IDIQ and associated delivery orders aim to maintain the health and medical readiness of military personnel by providing a reliable supply of pharmaceuticals and critical care products for DOD medical treatment facilities on an as-needed basis. No set-aside provisions or subcontracting were specified under the contract awards.